keyword
MENU ▼
Read by QxMD icon Read
search

lymphoma, leukemia, aplastic

keyword
https://www.readbyqxmd.com/read/27722132/changes-in-serum-uric-acid-levels-after-allogeneic-hematologic-stem-cell-transplantation-a-retrospective-cohort-study
#1
Sang Hyun Joo, Jin Kyun Park, Eunyoung Emily Lee, Yeong Wook Song, Sung-Soo Yoon
BACKGROUND: Since cell turnover in the hematopoietic system constitutes a major source of uric acid (UA) production, we investigated whether hematopoietic stem cell transplantation (HSCT) is associated with significant changes in serum UA levels in patients with hematological disorders. METHODS: Patients who underwent HSCT at our institution between 2001 and 2012 were retrospectively enrolled. Serum UA levels at 3 months before, 1 week before, and 3 months and 1 year after HSCT were examined...
September 2016: Blood Research
https://www.readbyqxmd.com/read/27094950/bk-virus-hemorrhagic-cystitis-following-allogeneic-stem-cell-transplantation-clinical-characteristics-and-utility-of-leflunomide-treatment
#2
Young Hoon Park, Joo Han Lim, Hyeon Gyu Yi, Moon Hee Lee, Chul Soo Kim
: BK virus-hemorrhagic cystitis (BKV-HC) is a potential cause of morbidity and mortality in patients having undergone allogeneic stem cell transplantation (Allo-SCT). We analyzed the clinical features of BKV-HC following Allo-SCT and reported the utility of leflunomide therapy for BKV-HC. MATERIALS AND METHODS: From January 2005 to June 2014, among the 69 patients underwent Allo-SCT in our institution, the patients who experienced BKV-HC were investigated retrospectively...
April 18, 2016: Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology
https://www.readbyqxmd.com/read/27052362/evaluation-of-the-efficacy-and-safety-of-original-filgrastim-neupogen%C3%A2-biosimilar-filgrastim-leucostim%C3%A2-and-lenograstim-granocyte%C3%A2-in-cd34-peripheral-hematopoietic-stem-cell-mobilization-procedures-for-allogeneic-hematopoietic-stem-cell-transplant-donors
#3
Serdar Sivgin, Esen Karakus, Muzaffer Keklik, Gokmen Zararsiz, Musa Solmaz, Leylagul Kaynar, Bulent Eser, Mustafa Cetin, Ali Unal
OBJECTIVES AND AIM: In this study, we aimed to compare the potency of different G-CSF agents including original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) on CD34(+) cell mobilization in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT). PATIENTS AND METHODS: The data of 243 donors for alloHSCT recipients diagnosed with mostly acute leukemia and myelodsyplastic syndromes (MDS) were analyzed, retrospectively...
June 2016: Transfusion and Apheresis Science
https://www.readbyqxmd.com/read/26969769/nutritional-assessment-as-predictor-of-complications-after-hematopoietic-stem-cell-transplantation
#4
Marcela Espinoza, Javiera Perelli, Roberto Olmos, Pablo Bertin, Verónica Jara, Pablo Ramírez
INTRODUCTION: Nutritional support is pivotal in patients submitted to hematopoietic stem cell transplantation. Nutritional status has been associated with time of engraftment and infection rates. In order to evaluate the association between nutritional parameters and clinical outcomes after transplantation a cohort of transplant patients was retrospectively evaluated. METHODS: All 50 patients transplanted between 2011 and 2014 were included. The nutritional status before transplantation, ten days after transplantation and before discharge was assessed including anthropometry, body mass index, albumin, prealbumin and total urinary nitrogen...
January 2016: Revista Brasileira de Hematologia e Hemoterapia
https://www.readbyqxmd.com/read/26452331/hematopoietic-stem-cell-transplantation-in-the-eastern-mediterranean-region-emro-2011-2012-a-comprehensive-report-on-behalf-of-the-eastern-mediterranean-blood-and-marrow-transplantation-group-embmt
#5
Mahmoud Aljurf, Amr Nassar, Amir Ali Hamidieh, Alaa Elhaddad, Rose-Marie Hamladji, Ali Bazarbachi, Ahmed Ibrahim, Tarek Ben Othman, Fawzi Abdel-Rahman, Amal Alseraihy, Omar Fahmy, Ayad Ahmed Hussein, Abdulaziz Alabdulaaly, Salman Adil, Salam Salim Amur Alkindi, Mohamed Bayoumy, David Dennison, Mohamed Amine Bekadja, Ahmed Nacer Redhouane, Walid Rasheed, Ahmed AlSagheir, Reem Alsudairy, Saloua Ladeb, Said Benchekroun, Mani Ramzi, Parvez Ahmed, Hassan ElSolh, Syed Osman Ahmed, Fazal Hussain, Ardeshir Ghavamzadeh
OBJECTIVE/BACKGROUND: The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) group has accumulated over 31 years of data and experience in hematopoietic stem cell transplantation (HSCT), particularly in hemoglobinopathies, severe aplastic anemia, inherited metabolic and immune disorders, in addition to a wide array of hematologic malignancies unique to this region. A regional update in current HSCT trends is highly warranted. We studied the trends of HSCT activities in World Health Organization-Eastern Mediterranean (EMRO) region, surveyed by the EMBMT, between 2011 and 2012...
December 2015: Hematology/oncology and Stem Cell Therapy
https://www.readbyqxmd.com/read/26306064/safety-and-efficacy-of-eltrombopag-in-post-hematopoietic-stem-cell-transplantation-hsct-thrombocytopenia
#6
Shreeniwas S Raut, Sandip A Shah, Vijay V Sharanangat, Kamlesh M Shah, Kinnari A Patel, Asha S Anand, Shailesh S Talati, Harsha P Panchal, Apurva A Patel, Sonia K Parikh, Shilin N Shukla
Twelve adult patients (median age 29.5 years) were started on Eltrombopag 25-50 mg/day for post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia. All patients were having primary thrombocytopenia after HSCT. No patient had other secondary cause for thrombocytopenia. Two patients were allogenic subsets (1 acute myeloid leukemia i.e., AML and 1 aplastic anemia), and 10 were autologous transplants (3 multiple myeloma, 6 lymphoma and 1 AML). Nine patients were males, three were females. The median time of starting Eltrombopag was 21 days post-stem cell infusion (range day +17 to +60) at a median platelet count of 9,000/cmm (range 3,000-11,000/cmm)...
December 2015: Indian Journal of Hematology & Blood Transfusion
https://www.readbyqxmd.com/read/25778892/-analysis-of-blood-cell-autophagy-distribution-in-hematologic-diseases-by-transmission-electron-microscope
#7
Shuxu Dong, Shixuan Zhao, Ying Wang, Tianxiang Pang, Yongxin Ru
OBJECTIVE: To investigate the distribution characteristics of blood cells autophagy in hematologic diseases, as well as their possible pathomechanism. METHODS: Retrospective analysis of electron microscopy specimens of 3 277 patients with hematological diseases were performed. The blood cells autophagy was observed by transmission electron microscopy, and its distribution characteristics were analyzed. The pathomechanism of blood cell autophagy was explored in combination with clinical examination and diagnosis...
February 2015: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://www.readbyqxmd.com/read/25722722/hematopoietic-stem-cell-transplantation-in-the-developing-world-experience-from-a-center-in-western-india
#8
Chirag A Shah, Arun Karanwal, Maharshi Desai, Munjal Pandya, Ravish Shah, Rutvij Shah
We describe our experience of first 50 consecutive hematopoietic stem-cell transplants (HSCT) done between 2007 and 2012 at the Apollo Hospital, Gandhinagar, 35 autologous HSCT and 15 allogeneic HSCT. Indications for autologous transplant were multiple myeloma, non-Hodgkin lymphoma, Hodgkin lymphoma, and acute myeloid leukemia, and indications for allogeneic transplants were thalassemia major, aplastic anaemia, chronic myeloid leukemia, and acute lymphoblastic and myeloid leukaemia. The median age of autologous and allogeneic patient's cohort was 50 years and 21 years, respectively...
2015: Journal of Oncology
https://www.readbyqxmd.com/read/25247760/population-pharmacokinetics-and-individualized-dosage-prediction-of-cyclosporine-in-allogeneic-hematopoietic-stem-cell-transplant-patients
#9
Ling Xue, Wen-Wen Zhang, Xiao-Liang Ding, Jing-Jing Zhang, Jian-An Bao, Li-Yan Miao
BACKGROUND: Cyclosporine (CsA), a potent immunosuppressive agent used to prevent rejection, is characterized by large individual variability. The purpose of this study was to explore the pharmacokinetic characteristics of CsA and establish a CsA population pharmacokinetic model that could be used for personalized therapy in allogeneic hematopoietic stem cell transplant (allo-HSCT) patients. METHODS: Clinical data were obtained from 117 allo-HSCT patients. The data analysis was performed using NONMEM software...
December 2014: American Journal of the Medical Sciences
https://www.readbyqxmd.com/read/25216687/cluster-and-sporadic-cases-of-herbaspirillum-species-infections-in-patients-with-cancer
#10
Roy F Chemaly, Raymund Dantes, Dimpy P Shah, Pankil K Shah, Neil Pascoe, Ella Ariza-Heredia, Cheryl Perego, Duc B Nguyen, Kim Nguyen, Farhad Modarai, Heather Moulton-Meissner, Judith Noble-Wang, Jeffrey J Tarrand, John J LiPuma, Alice Y Guh, Tara MacCannell, Issam Raad, Victor Mulanovich
BACKGROUND: Herbaspirillum species are gram-negative Betaproteobacteria that inhabit the rhizosphere. We investigated a potential cluster of hospital-based Herbaspirillum species infections. METHODS: Cases were defined as Herbaspirillum species isolated from a patient in our comprehensive cancer center between 1 January 2006 and 15 October 2013. Case finding was performed by reviewing isolates initially identified as Burkholderia cepacia susceptible to all antibiotics tested, and 16S ribosomal DNA sequencing of available isolates to confirm their identity...
January 1, 2015: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/25119132/changes-in-circulating-endothelial-cells-count-could-become-a-valuable-tool-in-the-diagnostic-definition-of-acute-graft-versus-host-disease
#11
Camillo Almici, Cristina Skert, Rosanna Verardi, Andrea Di Palma, Andrea Bianchetti, Arabella Neva, Simona Braga, Michele Malagola, Alessandro Turra, Mirella Marini, Domenico Russo
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is burdened by life-threatening complications, with graft-versus-host disease (GvHD) being the major cause of morbility and mortality. Recently, clinical and physiopathologic evidences showed that vascular endothelium can be a target of GvHD in the early phase and circulating endothelial cells (CECs) represent surrogate markers of endothelial damage. METHODS: Using the CellSearch System (Veridex LLC, Raritan, NJ), CECs were counted before (T1), after conditioning regimen (T2), at engraftment (T3), at GvHD onset (T4), and after steroid treatment (T5) in 40 patients (7 Hodgkin's Disease, 13 Acute Myeloblastic Leukemia, 5 Acute Lymphoblastic Leukemia, 8 Multiple Myeloma, 3 Chronic Lymphocytic Leukemia, 1 Non-Hodgkin Lymphoma, 1 Chronic Myeloid Leukemia, 2 Severe Aplastic Anemia) undergoing allo-HSCT...
October 15, 2014: Transplantation
https://www.readbyqxmd.com/read/25105934/a-review-of-important-skin-disorders-occurring-in-the-posttransplantation-patient
#12
REVIEW
Uma Sundram
Hematopoietic stem cell transplantation continues to be the mainstay of treatment for many hematologic dyscrasias and malignancies, including acute leukemias, lymphomas, and aplastic anemia. There can be significant complications, however, and often these complications are manifested in the skin as an eruption. Common among these are acute and chronic graft-versus-host disease, erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis, eruption of lymphocyte recovery, staphylococcal scalded skin syndrome, morbiliform drug eruptions, infections, and toxic erythema of chemotherapy...
September 2014: Advances in Anatomic Pathology
https://www.readbyqxmd.com/read/24982073/monitoring-of-trough-plasma-ganciclovir-levels-and-peripheral-blood-cytomegalovirus-cmv-specific-cd8-t-cells-to-predict-cmv-dnaemia-clearance-in-preemptively-treated-allogeneic-stem-cell-transplant-recipients
#13
Estela Giménez, Carlos Solano, José Ramón Azanza, Paula Amat, David Navarro
It is uncertain whether monitoring plasma ganciclovir (GCV) levels is useful in predicting cytomegalovirus (CMV) DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients. In this observational study, including 13 episodes of CMV DNAemia treated with intravenous (i.v.) GCV or oral valganciclovir, we showed that monitoring trough plasma GCV levels does not reliably predict response to therapy. Rather, immunological monitoring (pp65 and immediate-early [IE]-1-specific gamma interferon [IFN-γ]-producing CD8+ T cells) appeared to perform better for this purpose...
September 2014: Antimicrobial Agents and Chemotherapy
https://www.readbyqxmd.com/read/24830725/a-rare-polymorphic-variant-of-nbs1-reduces-dna-repair-activity-and-elevates-chromosomal-instability
#14
Yuki Yamamoto, Mamiko Miyamoto, Daisuke Tatsuda, Michiaki Kubo, Hitoshi Nakagama, Yusuke Nakamura, Hitoshi Satoh, Koichi Matsuda, Toshiki Watanabe, Tsutomu Ohta
Failure to expeditiously repair DNA at sites of double-strand breaks (DSB) ultimately is an important etiologic factor in cancer development. NBS1 plays an important role in the cellular response to DSB damage. A rare polymorphic variant of NBS1 that resulted in an isoleucine to valine substitution at amino acid position 171 (I171V) was first identified in childhood acute lymphoblastic leukemia. This polymorphic variant is located in the N-terminal region that interacts with other DNA repair factors. In earlier work, we had identified a remarkable number of structural chromosomal aberrations in a patient with pediatric aplastic anemia with a homozygous polymorphic variant of NBS1-I171V; however, it was unclear whether this variant affected DSB repair activity or chromosomal instability...
July 15, 2014: Cancer Research
https://www.readbyqxmd.com/read/24750685/aplastic-anemia-possible-associations-with-lymphoproliferative-neoplasms
#15
REVIEW
A Tzankov, M Medinger
Aplastic anemia (AA) may precede, co-occur, or follow a lymphoproliferative neoplasm. The best molecularly clarified scenario is that of concurrent AA and unsuspected (occult) T-cell large granular lymphocyte leukemia. Several reported cases of AA and concurrent small B-cell lymphomas/leukemias and Hodgkin lymphomas suggest also a possible link to simultaneous or preceding AA that might be sought in an antineoplastic immunological attempt to 'eradicate' the underlying malignant clone. The 'immuno-deregulatory' potential and the direct cytotoxicity of regimens used for lymphoma therapy might be able to trigger AA in cases evolving after lymphoma treatment too...
June 2014: International Journal of Laboratory Hematology
https://www.readbyqxmd.com/read/24705981/stat3-inhibitors-finding-a-home-in-lymphoma-and-leukemia
#16
REVIEW
Javier Munoz, Navjot Dhillon, Filip Janku, Stephanie S Watowich, David S Hong
The Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathway is an active mediator of cytokine signaling in the pathogenesis of solid and hematologic malignancies. The seven-member STAT family is composed of latent cytoplasmic transcription factors that are activated by phosphorylation intertwined in a network with activation that ultimately leads to cell proliferation. An activated kinase enzyme phosphorylates one STAT factor or more, which shuttle to the nucleus to regulate gene expression, promoting cell survival...
May 2014: Oncologist
https://www.readbyqxmd.com/read/24455111/comparative-evaluation-of-bone-marrow-aspirate-with-trephine-biopsy-in-hematological-disorders-and-determination-of-optimum-trephine-length-in-lymphoma-infiltration
#17
Surbhi Goyal, Usha Rani Singh, Usha Rusia
INTRODUCTION: Bone marrow examination is an indispensable diagnostic tool to evaluate neoplastic and non neoplastic hematological diseases. AIMS: To compare bone marrow aspirate with trephine biopsy in hematological disorders. To determine the optimum trephine preprocessing length in lymphoma infiltration. METHODS: Diagnostic comparison was done between simultaneous bone marrow aspirates and trephine biopsies in 449 patients. Biopsies were fixed in formalin, decalcified in 5...
January 2, 2014: Mediterranean Journal of Hematology and Infectious Diseases
https://www.readbyqxmd.com/read/24395543/transient-liver-function-abnormality-following-treatment-with-rabbit-antithymocyte-globulin-for-nonmyeloablative-hematopoetic-stem-cell-transplant-two-case-reports
#18
Abraham Chang, Fu-Ying Lee-Lam, Joanna Wang, Ya-Hwei Cheng
Rabbit antithymocyte globulin (rATG) is increasingly used in nonmyeloablative hematopoetic stem cell transplant (HSCT). Elevated liver function tests (LFTs) have been reported for antithymocyte globulin in the treatment of aplastic anemia, but not when used in a conditioning regimen for HSCT. We describe two cases of patients receiving a conditioning regimen for HSCT containing rATG who developed a transient, severe transaminase elevation. In the first case, a 66-year-old woman with a history of acute myeloid leukemia received the first dose of rATG and the patient's transaminases were found to be extremely elevated within a few hours...
February 2015: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/24383458/patterns-of-hospice-use-in-patients-dying-from-hematologic-malignancies
#19
Amy Sexauer, M Jennifer Cheng, Louise Knight, Anthony W Riley, Lauren King, Thomas J Smith
BACKGROUND: Hospice brings substantial clinical benefits to dying patients and families but is underutilized by patients dying of hematologic malignancies (HM); nationwide, only 2% of HM patients use hospice. There are 70,000 deaths among U.S. patients with hematologic malignancies yearly. OBJECTIVE: We measured the use and length of stay (LOS) in hospice among patients with HMs at a large academic cancer center. DESIGN: This was a single center retrospective review of adult patients (≥18 years) with lymphoma, leukemia, myelodysplastic syndrome, aplastic anemia, and multiple myeloma referred for hospice...
February 2014: Journal of Palliative Medicine
https://www.readbyqxmd.com/read/24294271/breakthrough-filamentous-fungal-infections-in-pediatric-hematopoetic-stem-cell-transplant-and-oncology-patients-receiving-caspofungin
#20
Shaun K Morris, Upton D Allen, Sumit Gupta, Susan E Richardson
BACKGROUND: Caspofungin is an echinocandin class antifungal medication that is commonly used empirically in immunocompromised patients at high risk for invasive fungal disease. OBJECTIVE: To describe the clinical characteristics of breakthrough fungal infections in pediatric hematopoetic stem cell transplant recipients, and oncology and hematology patients receiving caspofungin. METHODS: A five-year retrospective review, from 2004 through 2008, of all cases of proven invasive filamentous fungal infection of children admitted to The Hospital for Sick Children (Toronto, Ontario) was conducted...
2012: Canadian Journal of Infectious Diseases & Medical Microbiology
keyword
keyword
89257
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"